Handelsavisen
prelaunch
Companies Healthcare CNC.V
CN
CNC.V TSX Venture Healthcare Services & Equipment

Cnc.V

$1,50
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
ROE
-11,8 %
Net margin
Debt / equity
0,19
Beta
52w range
Volume
Day range
Prev close
$63,74
Open
Next earnings
Ex-dividend
TR 1Y
About

CNC.V operates in the specialty mining and metals industry, focusing on the extraction and processing of non-ferrous metals and minerals.

Business. CNC.V operates in the specialty mining and metals industry, focusing on the extraction and processing of non-ferrous metals and minerals.

Classification99 %
SectorHealth Care
Industry groupHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY3 analysts
3 buy0 hold0 sell
Avg 12m price target3,25

Analyst recommendations

3 analysts · consensus Buy
Buy3
Hold0
Sell0
12-month price target
3,25
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
3 analysts · indicative
Ownership
not yet wired
Profitability
-11,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CNC.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,7 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Consumer Discretionary+0,4 %+7,7 %−0,2 %
    Information Technology+0,3 %+7,8 %−0,3 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CNC.V. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    CNC.V operates in the specialty mining and metals industry, focusing on the extraction and processing of non-ferrous metals and minerals.

    Classification99 %
    SectorHealth Care
    Industry groupHealthcare Services & Equipment
    AI synthesis
    GENERATED

    CNC.V's capital structure is characterized by a debt-to-equity ratio of 0.19, indicating a relatively low level of leverage. The company's liquidity position is weak, as evidenced by a current ratio of 0.06, suggesting that it may struggle to meet short-term obligations with its current assets. The company's free cash flow is negative at -71.5 million CAD, and its operating cash flow is also negative at -4.99 million CAD, indicating that it is not generating sufficient cash from operations to sustain its activities.

    In terms of profitability, CNC.V is underperforming, with a return on equity of -11.84% and a return on assets of -9.22%, both significantly below the industry median for specialty mining and metals. The company reported a net loss of 26.21 million CAD and an operating loss of 12.79 million CAD, reflecting poor operational performance and cost management.

    The company's revenue is primarily concentrated in a few segments and geographic regions, as disclosed in its financial reports. However, the specific segments and geographic breakdown are not detailed in the available data. This lack of diversification could pose a risk to the company's stability, especially in volatile markets.

    Looking at the growth trajectory, CNC.V is expected to face challenges in the current fiscal year, with a negative outlook on revenue and profitability. The company's capital expenditure of 45.53 million CAD indicates ongoing investment in its operations, but the lack of positive cash flow suggests that these investments may not be yielding the desired returns. The company's future performance will depend on its ability to improve operational efficiency and generate positive cash flow.

    The risk assessment for CNC.V highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could impact its ability to fund operations and investments. The company has not indicated any significant dilution sources in the near term, but the potential for dilution remains a concern if the company needs to raise additional capital.

    Recent events and filings indicate that CNC.V is under pressure to improve its financial performance. The company's negative operating and net income, along with its weak liquidity position, have led to a mixed analyst outlook, with a mean price target of 3.25 CAD and a median price target of 3.25 CAD. The company's ability to address its financial challenges and improve its operational performance will be critical in determining its future success.

    Key takeaways
    • CNC.V is experiencing significant financial distress, with negative operating and net income.
    • The company's liquidity position is weak, with a current ratio of 0.06 and negative free cash flow.
    • CNC.V's profitability metrics are well below industry medians, indicating poor operational performance.
    • The company's capital expenditure is substantial, but it is not generating positive cash flow from operations.
    • Analysts have a mixed outlook on CNC.V, with a mean price target of 3.25 CAD and no strong buy recommendations.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $1,50
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $221.4M
    Net cash
    -$39.7M
    Current ratio
    0.1
    Debt / equity
    0.2
    ROA
    -9.2%
    ROE
    -11.8%
    Cash conversion
    19.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYHealthcareIndustryHealthcare Services & Equipment1 272,5B node revenueUNH 35,2%CI 21,6%ELV 15,7%CNC 13,7%HUM 10,2%MOH 3,6%PGNY 0,1%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)CNC 13,7% · rank #4 of 7

    Business relationships

    Business relationships1 disclosed relationship · 1 type · extracted from filings & disclosures
    Subsidiaries1
    EX21:b939451c5bb5EX21:b939451c5bb5Subsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    Peer comparison6 peers · vs CNC · multiples and returns
    UN
    UNH
    UNITEDHEALTH GROUP INCORPORATED
    $415,25
    377,9B USD
    P/E
    33,7x
    vs self
    Div yield
    2,0 %
    vs self
    ROE
    11,6 %
    +42,8 vs self
    CI
    CI
    The Cigna Group
    $282,06
    74,5B USD
    P/E
    13,1x
    vs self
    Div yield
    2,1 %
    vs self
    ROE
    14,0 %
    +45,1 vs self
    EL
    ELV
    Elevance Health Inc
    $384,27
    84,2B USD
    P/E
    14,6x
    vs self
    Div yield
    vs self
    ROE
    12,6 %
    +43,8 vs self
    HU
    HUM
    Humana Inc
    $363,19
    43,8B USD
    P/E
    39,5x
    vs self
    Div yield
    0,9 %
    vs self
    ROE
    6,4 %
    +37,5 vs self
    MO
    MOH
    Molina Healthcare Inc
    $196,26
    10,0B USD
    P/E
    24,4x
    vs self
    Div yield
    vs self
    ROE
    11,6 %
    +42,8 vs self
    PG
    PGNY
    Progyny Inc
    $31,53
    2,5B USD
    P/E
    34,0x
    vs self
    Div yield
    vs self
    ROE
    11,3 %
    +42,5 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -0,07
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    3
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-04 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate-0,07
    Revenueno estimateno estimateno estimate
    Operating incomeno estimateno estimateno estimate
    Full-year consensus mean (period as reported by source) · consensus in CAD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution3 analysts
    Strong buy0
    Buy3
    Hold0
    Sell0
    Strong sell0
    12-month price target$3,25 · Median $3,25
    Low $3,00High $3,50
    EPS surprise
    −85,7 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$3,00
    Mean$3,25
    Median$3,25
    High$3,50
    Spot$1,50
    +116.7 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    ROE-11,8 %Bottom quartile
    D/E0,19Best in class
    Cash Conv0,19Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • CNC.V Market data — financials · 2026-05-27
    • Canada Nickel Company Inc Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Leadership

    • Mark T. H. SelbyPresident, Chief Executive Officer, Director

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CNC.VCanonical
    TSX Venture · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    CNCEX21:b93Healthcare Ser
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-28 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-28EVENTQ2 2026 earnings (confirmed · filed)
    2026-07-28INSIDERDIAZ PAUL J transacted 2.8k sh — Director
    2026-07-18 12:41 UTCNEWSFanuc Corp thesis revised as Nvidia expands AI robotics partnership in Japan → The industrial automation leader is deepening ties with Nvidia and Yaskawa, signaling a strategic pivot toward AI-driven manufacturing solutions.
    2026-07-17INSIDERTyler Lauren M transacted 3.2k sh — Director
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-30INSIDEREPPINGER FREDERICK H transacted 833 sh — Director
    2026-06-30INSIDERCOUGHLIN CHRISTOPHER J transacted 562 sh — Director
    2026-06-30INSIDERSamuels Theodore R. II transacted 465 sh — Director
    2026-06-30INSIDERTANJI KENNETH transacted 581 sh — Director
    2026-06-30INSIDERTyler Lauren M transacted 61 sh — Director
    2026-06-26 03:13 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-25 03:10 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-15 00:00 UTCINSIDER2 insider transactions — 2026-06 · net sell $5.2M
    2026-06-15 00:00 UTCINSIDER2 insider transactions — 2026-06 · net sell $5.2M
    2026-06-15INSIDERSMITH SUSAN RAYE transacted 483 sh — Chief Operating Officer ~$31k
    2026-06-10INSIDERBurdick Kenneth A sold 80.0k sh — Director ~$5.16M
    2026-05-29 00:00 UTCINSIDER10 insider transactions — 2026-05 2 derivative
    2026-05-29 00:00 UTCINSIDER10 insider transactions — 2026-05 2 derivative
    2026-05-29INSIDERCarson Michael A disposed of 604 sh Phantom Stock — Group President, Medicare&Spec
    2026-05-22INSIDERCarson Michael A acquired 48 sh Phantom Stock — Group President, Medicare&Spec
    2026-05-15FILING8-K filing →
    2026-05-12INSIDERSamuels Theodore R. II transacted 4.0k sh — Director
    2026-05-12INSIDEREPPINGER FREDERICK H transacted 6.7k sh — Director
    2026-05-12INSIDERBLUME JESSICA L. transacted 4.0k sh — Director
    2026-05-12INSIDERBurdick Kenneth A transacted 4.0k sh — Director
    2026-05-12INSIDERCOUGHLIN CHRISTOPHER J transacted 4.0k sh — Director
    2026-05-12INSIDERDallas H James transacted 4.0k sh — Director
    2026-05-12INSIDERFORD MONTE E transacted 4.0k sh — Director
    2026-05-12INSIDERTANJI KENNETH transacted 4.0k sh — Director
    2026-04-28FILING8-K filing →
    2026-04-28FILING10-Q filing →
    2026-04-15 00:00 UTCINSIDER1 insider transaction — 2026-04
    2026-04-15 00:00 UTCINSIDER1 insider transaction — 2026-04
    2026-04-15INSIDERMCNALLY TANYA M transacted 964 sh — Chief People Officer ~$36k
    2026-03-31 00:00 UTCINSIDER8 insider transactions — 2026-03 · net sell $1.8M
    2026-03-31 00:00 UTCINSIDER8 insider transactions — 2026-03 · net sell $1.8M
    Showing the 40 most recent of 66 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage